Laronde is pioneering a platform that offers a completely novel way of modulating human biology. Endless RNA™ (eRNA), is a uniquely engineered RNA that can be programmed to express diverse proteins inside the body. It is persistent, non-immunogenic, allows for repeat dosing, and offers flexibility in formulation and delivery. Laronde was founded in 2017 by Flagship Labs, the innovation foundry of Flagship Pioneering. The company is rapidly scaling to support the parallel development of multiple programs across many disease areas.
Location: United States, Massachusetts, Cambridge
Employees: 11-50
Total raised: $440M
Founded date: 2017
Investors 3
| Date | Name | Website |
| - | Longevity ... | longevity.... |
| - | Altitude L... | altitudels... |
| - | Longevity ... | lvf.vc |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 31.08.2021 | Series B | $440M | - |
Mentions in press and media 6
| Date | Title | Description |
| 31.08.2021 | Flagship-backed Laronde nabs $440M | Biotech startup Laronde has raised $440 million in a Series B round backed by Flagship Pioneering, T. Rowe Price, Invus and others. The Cambridge, Mass.-based company was created within Flagship Labs in 2017 and develops programmable RNA fo... |
| 30.08.2021 | Flagship’s Laronde raises $440 million for a new class of medicines | Flagship Pioneering, the Cambridge, Mass., venture capital firm, brought biotech startup Laronde out of stealth mode in May, launching it with $50 million after four years of secrecy. It was the first time Laronde disclosed its technology: ... |
| 30.08.2021 | Laronde Attracts $440M in First External Financing to Further Advance Endless RNA™ Platform | |
| 30.08.2021 | Laronde Raises $440M in Series B Financing | Laronde, a Cambridge, Mass.-based company advancing Endless RNA™ (eRNA) – a novel, engineered form of RNA that can be programmed to express therapeutic proteins inside the body, raised $440M in Series B financing. The round included the com... |
| 11.05.2021 | Laronde launches with $50M from Flagship Pioneering | Biotech startup Laronde has launched with $50 million in capital from VC firm Flagship Pioneering. Cambridge, Mass.-based Laronde, which was founded in 2017 by Flagship Labs, is creating an engineered form of RNA capable of producing therap... |
| 10.05.2021 | Daily funding roundup - May 10th, 2021 | Kin raised $63.9M; Vanta landed $50M; Blind picks up $37; Elucid secures $8M Forge Global: Forge Global is a San Francisco-based private securities marketplace. Forge Global has closed a new financing round with $150 million. Backers in the... |